Pharma
PODCAST EPISODE 314 Click here to watch the video version of this podcast. Daniel Chao, MD, PhD, spent a lot of years in the lab…
Read MorePODCAST EPISODE 313 Click here to watch the video version of this podcast. A new generation of drug-delivery technology is emerging, with new refillable, absorbable, and…
Read MorePODCAST EPISODE 312 Click here to watch the video version of this podcast. Brian Strem, president and CEO of Kiora Pharmaceuticals, didn’t plan to become…
Read MorePODCAST EPISODE 309 Click here to watch the video version of this podcast. Even the most experienced physicians encounter patients with conditions they can’t solve…
Read MoreDespite a sharp dive in its stock price a day after reporting mixed topline results from two Phase III clinical trials of its lead candidate…
Read MorePODCAST EPISODE 297 Click here to watch the video version of this podcast. Damon Burrows isn’t a scientist. And he didn’t start IACTA Pharmaceuticals, an…
Read MoreAmydis is developing novel small-molecule contrast agents that aim to enable the direct visualization of central nervous system (CNS) disease-related biomarkers in the retina. The…
Read MoreA number of companies are developing drug treatments for geographic atrophy, the result of advanced dry age-related macular degeneration (AMD), for which no approved treatments…
Read MoreWeeks after receiving Food and Drug Administration approval for its complement factor 3 (C3) inhibitor pegcetacoplan, now known as Empaveli, to treat adults who have…
Read MoreMoney is pouring into digital health at a record clip – $6.7 billion in the first quarter this year, the investment firm Rock Health reports.…
Read MoreIn 2020 Innovega, which is headquartered in Bellevue, WA, and has development facilities in San Diego, was recognized in a listing of “Cool Companies” selected…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.